Importantly, concurrent treatment with both bispecific adapters induced nearly complete tumor eradication, demonstrating that diversion of some universal CAR T cells to engage FAP-expressing stromal cells (i.e. CAFs) not only did not hinder but actually augmented their abilities to inhibit tumor growth. The gene discussed is FAP; the disease is neoplasm.